Capstone Investment Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,800
Closed -$678K 1700
2022
Q2
$678K Hold
16,800
﹤0.01% 1149
2022
Q1
$1.11M Buy
+16,800
New +$1.15M ﹤0.01% 1272

Other funds holding GH

Capstone Investment Advisors's GH Position: Q1 2026 in Review

Capstone Investment Advisors sold out of Guardant Health (GH) in Q1 2026, closing a stake of 2,239 shares — an estimated $229K sold.

Capstone Investment Advisors first reported a position in GH in Q1 2022 and held it in 6 quarters. The position peaked at $2.36M in Q3 2025. 484 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Capstone Investment Advisors reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 2,239 Guardant Health shares in Q1 2026, an estimated $229K.
  • Capstone Investment Advisors first reported a position in Guardant Health in Q1 2022 and held it in 6 quarters.
  • Capstone Investment Advisors's Guardant Health position peaked at $2.36M in Q3 2025.
  • 484 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.